ACADIA Pharmaceuticals Inc. vs Open Text Corporation — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Open Text Corporation trades at $23.98 (market cap $5.80B). The key difference: ACADIA Pharmaceuticals Inc. and Open Text Corporation are close in size by market cap, and Open Text Corporation pays a 4.67% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | OTEX | |
|---|---|---|
Market Cap | $5.07B | $5.80B |
Sector | Health | Technology |
52-Week High | $29.41 | $39.69 |
52-Week Low | $20.06 | $20.01 |
Enterprise Value | $4.19B | $10.81B |
Dividend Yield | — | 4.67% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →